NLRP3 and colorectal cancer: In agreement with these findings, we found that NLRP3 is highly expressed in the tumor tissues of patients with colorectal cancer and that CAPE protected mice from AOM/DSS-induced CAC by inhibiting NLRP3 inflammasome.